Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Lung Cancer Screening and Prevention Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2026 · third_quarter · Q3
H.R. 8800 / H. Res. 1398 / S. 4784 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices.
Issues related to medical supply chain resiliency and procurement; and Issues related to access to artificial intelligence models.
Source: Senate LDA
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
ROCR Value Based Program Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Women and Lung Cancer Research and Preventive Services Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
Women and Lung Cancer Research and Preventive Services Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Portable Ultrasound Reimbursement Equity Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Portable Ultrasound Reimbursement Equity Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Increasing Access to Lung Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
National Defense Authorization Act for Fiscal Year 2027
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 8800 / H. Res. 1398 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices. Issues related to Veterans Affairs healthcare.
National Defense Authorization Act for Fiscal Year 2027
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 8800 / H. Res. 1398 / S. 4784 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H. Rept. 119-632 / H. Res. 1333 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 - issues related to funding for the Food & Drug Administration; and H.R. 9260 / H. Rept. 119-696 - Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2027 - issues related to artificial intelligence and funding for Department of Human Services & National Institutes of Health.
Providing for consideration of the bill (H.R. 8646) making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2027, and for other purposes; providing for consideration of the bill (H.R. 7726) to amend the Child Care and Development Block Grant Act of 1990 to withhold funds from noncompliant States under such Act; providing for consideration of the bill (H.R. 7892) to amend the Higher Education Act of 1965 to require to the Secretary of Education to use an identity fraud detection system to review each FAFSA to determine whether the FAFSA presents a reasonable suspicion of identity fraud; and providing for consideration of the bill (H.R. 8872) to amend part A of title IV of the Social Security Act to target funds to low-income families, strengthen program integrity guardrails for State expenditure of funds, require measurement of improper payments, and establish goals for eliminating fraud and improper payments under the program of block grants to States for temporary assistance for needy families, and for other purposes.
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
Providing for consideration of the bill (H.R. 8800) to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes; providing for consideration of the bill (H.R. 8595) making appropriations for national security, Department of State, and related programs for the fiscal year ending September 30, 2027, and for other purposes; providing for consideration of the bill (H.R. 8884) to amend title II of the Social Security Act to reauthorize demonstration authority for the disability insurance program; providing for consideration of the resolution (H. Res. 1383) commemorating the one-year anniversary of the enactment of the Working Families Tax Cuts; and for other purposes.
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 8800 / H. Res. 1398 / S. 4784 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices.
Providing for consideration of the bill (H.R. 8800) to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes; providing for consideration of the bill (H.R. 8595) making appropriations for national security, Department of State, and related programs for the fiscal year ending September 30, 2027, and for other purposes; providing for consideration of the bill (H.R. 8884) to amend title II of the Social Security Act to reauthorize demonstration authority for the disability insurance program; providing for consideration of the resolution (H. Res. 1383) commemorating the one-year anniversary of the enactment of the Working Families Tax Cuts; and for other purposes.
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 8800 / H. Res. 1398 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices. Issues related to Veterans Affairs healthcare.
ROCR Value Based Program Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
ROCR Value Based Program Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Women and Lung Cancer Research and Preventive Services Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
Women and Lung Cancer Research and Preventive Services Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Portable Ultrasound Reimbursement Equity Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
Portable Ultrasound Reimbursement Equity Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
National Defense Authorization Act for Fiscal Year 2027
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 8800 / H. Res. 1398 / S. 4784 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices.
National Defense Authorization Act for Fiscal Year 2027
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 8800 / H. Res. 1398 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices. Issues related to Veterans Affairs healthcare.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 1 - One Big Beautiful Bill - provisions related to international tax provisions such as the Base Erosion and Anti-Abuse Tax; Foreign-Derived Intangible Income; and Global Intangible Low-Tax Income.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 1 - One Big Beautiful Bill - provisions related to international tax provisions such as the Base Erosion and Anti-Abuse Tax; Foreign-Derived Intangible Income; and Global Intangible Low-Tax Income.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Lung Cancer Screening and Prevention Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
Public Law 119 / H.R. 1968 - Full year Continuing Appropriations and Extensions Act.
ROCR Value Based Program Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2120 / S. 1031 - Radiation Oncology Case Rate Value Based Program Act; and S. 1399 - Health Tech Investment Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Women and Lung Cancer Research and Preventive Services Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
SCREENS for Cancer Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2381 -- SCREENS for Cancer Act of 2025. Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices, and potential future frameworks for generative AI; Issues related to Artificial Intelligence for medical devices; and Issues related to right to repair.
CREATE AI Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2385 - Create AI Act of 2025; S. 2750 - SANDBOX Act; and Issues related to data privacy, transparency, and cybersecurity.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 3838 - National Defense Authorization Act, 2026 - issues related to right to repair.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 3838 / S 2296 - National Defense Authorization Act, 2026 - issues related to right to repair and the BIOSECURE Act.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 3838 - National Defense Authorization Act, 2026 - issues related to right to repair.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026; and Draft Bill - Labor-HHS-Education Appropriation Act, FY 2026.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026; and Draft Bill - Labor-HHS-Education Appropriation Act, FY 2026.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 / S. 2256/H. Rept. 119-172/S. Rept. 119-37 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026 - issues related to FDA funding; H.R. 5304 / S. S587/H. Rept. 199-271, S. Rept. 119-55 - Labor-HHS-Education Appropriation Act, FY 2026 - issues related to HHS funding, NIH funding, and artificial intelligence; and H.R.5371 / S. 2882 - Continuing Appropriations and Extensions Act, 2026. - issues related to HHS funding, NIH funding, telehealth flexibilities, and the Hospital at Home programs.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 / S. 2256/H. Rept. 119-172/S. Rept. 119-37 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026 - issues related to FDA funding; H.R. 5304 / S. S587/H. Rept. 199-271, S. Rept. 119-55 - Labor-HHS-Education Appropriation Act, FY 2026 - issues related to HHS funding, NIH funding, and artificial intelligence; and H.R.5371 / S. 2882 - Continuing Appropriations and Extensions Act, 2026. - issues related to HHS funding, NIH funding, telehealth flexibilities, and the Hospital at Home programs.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 / S. 2256/H. Rept. 119-172/S. Rept. 119-37 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026 - issues related to FDA funding; H.R. 5304 / S. S587/H. Rept. 199-271, S. Rept. 119-55 - Labor-HHS-Education Appropriation Act, FY 2026 - issues related to HHS funding, NIH funding, and artificial intelligence; and H.R.5371 / S. 2882 - Continuing Appropriations and Extensions Act, 2026. - issues related to HHS funding, NIH funding, telehealth flexibilities, and the Hospital at Home programs.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
ROCR Value Based Program Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2120 / S. 1031 - Radiation Oncology Case Rate Value Based Program Act; and S. 1399 - Health Tech Investment Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Women and Lung Cancer Research and Preventive Services Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2120 / S. 1031 - Radiation Oncology Case Rate Value Based Program Act; and S. 1399 - Health Tech Investment Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Find It Early Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 / S. 2256/H. Rept. 119-172/S. Rept. 119-37 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026 - issues related to FDA funding; H.R. 5304 / S. S587/H. Rept. 199-271, S. Rept. 119-55 - Labor-HHS-Education Appropriation Act, FY 2026 - issues related to HHS funding, NIH funding, and artificial intelligence; and H.R.5371 / S. 2882 - Continuing Appropriations and Extensions Act, 2026. - issues related to HHS funding, NIH funding, telehealth flexibilities, and the Hospital at Home programs.
National Defense Authorization Act for Fiscal Year 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 3838 / S 2296 - National Defense Authorization Act, 2026 - issues related to right to repair and the BIOSECURE Act.
SANDBOX Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2385 - Create AI Act of 2025; S. 2750 - SANDBOX Act; and Issues related to data privacy, transparency, and cybersecurity.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Continuing Appropriations and Extensions and Other Matters Act, 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 / S. 2256/H. Rept. 119-172/S. Rept. 119-37 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026 - issues related to FDA funding; H.R. 5304 / S. S587/H. Rept. 199-271, S. Rept. 119-55 - Labor-HHS-Education Appropriation Act, FY 2026 - issues related to HHS funding, NIH funding, and artificial intelligence; and H.R.5371 / S. 2882 - Continuing Appropriations and Extensions Act, 2026. - issues related to HHS funding, NIH funding, telehealth flexibilities, and the Hospital at Home programs.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
Death Tax Repeal Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 / S. 2256/H. Rept. 119-172/S. Rept. 119-37 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026 - issues related to FDA funding; H.R. 5304 / S. S587/H. Rept. 199-271, S. Rept. 119-55 - Labor-HHS-Education Appropriation Act, FY 2026 - issues related to HHS funding, NIH funding, and artificial intelligence; and H.R.5371 / S. 2882 - Continuing Appropriations and Extensions Act, 2026. - issues related to HHS funding, NIH funding, telehealth flexibilities, and the Hospital at Home programs.
American Relief Act, 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 10515 and H.R. 10545 - American Relief Act of 2025 - provisions related to telehealth and acute hospital care waiver authorities.
American Relief Act, 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 10515 and H.R. 10545 - American Relief Act of 2025 - provisions related to telehealth and acute hospital care waiver authorities.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1544, / H.R. 1199, Facilitating Innovative Nuclear Diagnostics Act of 2023; H.R. 8404 / S.4330 - Radiation Oncology Case Rate Value Based Program Act of 2024; and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Issues related to Medicare reimbursement rates; and Issues related to Artificial Intelligence for Medical Devices, including issues related to Medicare reimbursement.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1544, H.R. 1199, Facilitating Innovative Nuclear Diagnostics Act of 2023; H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Issues related to lung cancer screening programs; Issues related to Centers for Medicare & Medicaid Services conversion factor for physician fee schedule; Issues related to Medicare reimbursement rates; Issues related to clinical lab tests; Issues related to Artificial Intelligence for Medical Devices, including issues related to Medicare reimbursement; and Issues related to patient access to breakthrough products.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1544, / H.R. 1199, Facilitating Innovative Nuclear Diagnostics Act of 2023; H.R. 8404 / S.4330 - Radiation Oncology Case Rate Value Based Program Act of 2024; and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Issues related to Medicare reimbursement rates; Issues related to reimbursement for AI; and Issues related to breast & lung cancer screening.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1544, H.R. 1199, Facilitating Innovative Nuclear Diagnostics Act of 2023; H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Issues related to lung cancer screening programs; Issues related to Centers for Medicare & Medicaid Services conversion factor for physician fee schedule; Issues related to Medicare reimbursement rates; Issues related to clinical lab tests; Issues related to Artificial Intelligence for Medical Devices, including issues related to Medicare reimbursement; and Issues related to patient access to breakthrough products.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1544, / H.R. 1199, Facilitating Innovative Nuclear Diagnostics Act of 2023; H.R. 8404 / S.4330 - Radiation Oncology Case Rate Value Based Program Act of 2024; and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Issues related to Medicare reimbursement rates; and Issues related to Artificial Intelligence for Medical Devices, including issues related to Medicare reimbursement.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 8404 / S.4330 - Radiation Oncology Case Rate Value Based Program Act of 2024; and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Issues related to medical supply chain resiliency and procurement.
H. Rept. 119-632 / H. Res. 1333 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 - issues related to funding for the Food & Drug Administration; and H.R. 9260 / H. Rept. 119-696 - Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2027 - issues related to artificial intelligence and funding for Department of Human Services & National Institutes of Health.
Issues related to Artificial Intelligence, cybersecurity and data for medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2026 · second_quarter · Q2
Implementation of P. L. 87-794 - Trade Expansion Act - issues related to domestic supply chain considerations for medical devices in regard to Section 232 investigations; and Implementation of P.L. 93-618 - Trade Act - issues related to domestic supply chain considerations for medical devices in regards to Section 301 investigations and reciprocal tariffs.
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Implementation of P. L. No 116-113 United States-Mexico-Canada Agreement Implementation Act - issues related to joint review. Issues related to medical supply chains and procurement; Issues related to critical minerals supply chains and production; and Issues related to international trade.
Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices; Issues related to Artificial Intelligence for medical devices; Issues related to the right to repair for medical devices; Issues related to 21 CFR Part 212 requirements good and safe manufacturing or radiopharmaceuticals.
H.R. 8800 / H. Res. 1398 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices. Issues related to Veterans Affairs healthcare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2026 · first_quarter · Q1
Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices; Issues related to Artificial Intelligence for medical devices; Issues related to data privacy standards and transparency; and Issues related to right to repair for medical devices.
Implementation of P. L. No 116-113 United States-Mexico-Canada Agreement Implementation Act - issues related to joint review; Issues related to medical supply chains and procurement; Issues related to critical minerals supply chains and production; and Issues related to international trade.
Implementation of P. L. 87-794 - Trade Expansion Act - issues related to domestic supply chain considerations for medical devices in regard to Section 232 investigations; and Implementation of P.L. 93-618 - Trade Act - issues related to domestic supply chain considerations for medical devices in regards to Section 301 investigations and reciprocal tariffs.
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2025 · second_quarter · 2A
H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026; and Draft Bill - Labor-HHS-Education Appropriation Act, FY 2026.
H.R. 1 - One Big Beautiful Bill - provisions related to international tax provisions such as the Base Erosion and Anti-Abuse Tax; Foreign-Derived Intangible Income; and Global Intangible Low-Tax Income.
Issues related to medical supply chains and procurement; and Issues related to international trade
Issues related to tariffs and supply chain resilience.
H.R. 3838 - National Defense Authorization Act, 2026 - issues related to right to repair.
Issues related to NIH funding; and Issues related to ARPA-H Funding.
Issues related to critical minerals supply chains and production.
Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices, and potential future frameworks for generative AI; Issues related to Artificial Intelligence for medical devices; and Issues related to data privacy and transparency.
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2025 · fourth_quarter · Q4
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
Issues related to medical supply chains and procurement; Issues related to critical minerals supply chains and production; and Issues related to international trade.
Issues related to tariffs and supply chain resilience; Issues related to tariffs on medical devices; and Implementation of P.L. 87-794 - Trade Expansion Act - issues related to Section 232.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2025 · third_quarter · Q3
Issues related to FDA & third-party regulation of AI and Machine Learning-enabled medical devices; Issues related to Artificial Intelligence for medical devices; and Issues related to data privacy, transparency and cybersecurity.
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2025 · second_quarter · Q2
Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices, and potential future frameworks for generative AI; Issues related to Artificial Intelligence for medical devices; and Issues related to data privacy and transparency.
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2025 · first_quarter · Q1
H.R. 2120 / S. 1031 - Radiation Oncology Case Rate Value Based Program Act; and S. 1399 - Health Tech Investment Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Public Law 119 / H.R. 1968 - Full year Continuing Appropriations and Extensions Act.
Public Law 115-97 (Tax Cut and Jobs Act) - issues related to expiring tax provisions.
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2024 · fourth_quarter · Q4
Issues related to availability of medical isotopes; and Issues related to medical supply chains and procurement.
S. 1840 / H.R. 3916 -- SCREENS for Cancer Act of 2023. Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices, and potential future frameworks for generative AI. Issues related to national data privacy. Issues related to Artificial Intelligence for medical devices; and Issues related to right to repair.
H.R. 8404 / S.4330 - Radiation Oncology Case Rate Value Based Program Act of 2024; and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2024 · third_quarter · Q3
Issues related to availability of medical isotopes; and Issues related to medical supply chains and procurement.
S. 4638, National Defense Authorization Act of 2025 / H.R. 8070, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 - provisions related to right to repair for medical devices.
H.R. 9027 / S. 4690, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025; and H.R. 9029, S. 4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2025; and H.R. 8580 / S. 4677 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2025 - provisions related to cancer screenings
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2024 · second_quarter · Q2
S. 1544, / H.R. 1199, Facilitating Innovative Nuclear Diagnostics Act of 2023; H.R. 8404 / S.4330 - Radiation Oncology Case Rate Value Based Program Act of 2024; and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Issues related to Medicare reimbursement rates; and Issues related to Artificial Intelligence for Medical Devices, including issues related to Medicare reimbursement.
H.R.8580 / S.4677- Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2025.
Issues related to Veteran Affairs health issues; and Health care issues in general.
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2024 · first_quarter · Q1
Implementation of Trade Act of 1974 regarding Section 301 tariffs.
Issues related to cancer screening for veteran affairs; Issues related to Veteran Affairs health issues; and Health care issues in general.
Issues related to Medicare payment for artificial intelligence.
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2023 · fourth_quarter · Q4
Implementation of Trade Act of 1974 regarding Section 301 tariffs; and Issues related to supply chain activity;
Issues related to FDAs Predetermined Change Control Plans; Issues related to FDA medical device modernization; H.R.8152 - American Data Privacy and Protection Act (117th Congress) - provisions related to patient privacy; and Issues related to Artificial Intelligence;
H.R. 1199 / S. 1544 - Facilitating Innovative Nuclear Diagnostics Act (FIND Act); Physician Fee Schedule / Reimbursement issues; and Artificial Intelligence for Medical Devices, including issues related to Medicare reimbursement;
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2023 · third_quarter · Q3
Site neutral payment policy; and Issues related to export controls and Russian sanctions.
Site neutral payment policy H.R. 1199 / S. 1544 - Facilitating Innovative Nuclear Diagnostics Act (FIND Act); H.R. 1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Artificial Intelligence for Medical Devices, including issues related to Medicare reimbursement; and Issues related to price transparency.
Issues related to workforce development of allied healthcare professionals.
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2023 · second_quarter · Q2
FY 2024 Appropriations Bill: Labor Health and Human Services, Education and Related Agencies and Agriculture - diagnostic imaging equipment and medical imaging issues.
Health care workforce shortages.
Site neutral payment policy.
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2023 · first_quarter · Q1
H.R. 1199: Facilitating Innovative Nuclear Diagnostics Act (FIND Act); HR 4006: the Fair Repair Act; HR 6566: the Freedom to Repair Act regarding right to repair and exempting medical devices; H.R. 1835/S. 1000 Saving Access to Laboratory Service Act of 2023 (SALSA Act); Physician Fee Schedule/Reimbursement Issues; Artificial Intelligence for Medical Devices; H.R. 3967 Honoring Our PACT Act, 2022.
Remanufacturing Medical Devices (Clarifying Remanufacturing to Protect Patient Safety Act) Right to Repair; Artificial Intelligence for imaging devices; S.3648/H.R. 748 CARES Act; H.R. 925 Heroes Act; H.R. 2369 VALID Act of 2023; H.R. 3967 Honoring Our PACT Act, 2022; Physician Fee Schedule/Reimbursement Issues.
H. Rept. 119-632 / H. Res. 1333 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 - issues related to funding for the Food & Drug Administration; and H.R. 9260 / H. Rept. 119-696 - Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2027 - issues related to artificial intelligence and funding for Department of Human Services & National Institutes of Health.
H.R. 4121 / S. 2256/H. Rept. 119-172/S. Rept. 119-37 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026 - issues related to FDA funding; H.R. 5304 / S. S587/H. Rept. 199-271, S. Rept. 119-55 - Labor-HHS-Education Appropriation Act, FY 2026 - issues related to HHS funding, NIH funding, and artificial intelligence; and H.R.5371 / S. 2882 - Continuing Appropriations and Extensions Act, 2026. - issues related to HHS funding, NIH funding, telehealth flexibilities, and the Hospital at Home programs.
Issues related to medical supply chains and procurement; and Issues related to international trade.
Issues related to tariffs and supply chain resilience; and Issues related to tariffs on medical devices.
H.R. 3838 / S 2296 - National Defense Authorization Act, 2026 - issues related to right to repair and the BIOSECURE Act.
Issues related to NIH funding; and Issues related to ARPA-H Funding.
Issues related to critical minerals supply chains and production.
H.R. 2385 - Create AI Act of 2025; S. 2750 - SANDBOX Act; and Issues related to data privacy, transparency, and cybersecurity.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026; and Draft Bill - Labor-HHS-Education Appropriation Act, FY 2026.
H.R. 1 - One Big Beautiful Bill - provisions related to international tax provisions such as the Base Erosion and Anti-Abuse Tax; Foreign-Derived Intangible Income; and Global Intangible Low-Tax Income.
Issues related to medical supply chains and procurement; and Issues related to international trade
Issues related to tariffs and supply chain resilience.
H.R. 3838 - National Defense Authorization Act, 2026 - issues related to right to repair.
Issues related to NIH funding; and Issues related to ARPA-H Funding.
Issues related to critical minerals supply chains and production.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Issues related to availability of medical isotopes; Issues related to medical supply chains and procurement; and Issues related to international trade.
Issues related to tariffs and supply chain resilience.
H.R. 2381 -- SCREENS for Cancer Act of 2025. Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices, and potential future frameworks for generative AI; Issues related to Artificial Intelligence for medical devices; and Issues related to right to repair.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 4638 / H.R. 8070 & H.R. 5009, National Defense Authorization Act of 2025- provisions related to right to repair for medical devices.
H.R. 10515 and H.R. 10545 - American Relief Act of 2025 - provisions related to telehealth and acute hospital care waiver authorities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to FDA guidance for remanufacturing of medical devices; Issues related to Artificial Intelligence for medical devices; and Issues related to right to repair.
S. 1544, / H.R. 1199, Facilitating Innovative Nuclear Diagnostics Act of 2023; H.R. 8404 / S.4330 - Radiation Oncology Case Rate Value Based Program Act of 2024; and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Issues related to Medicare reimbursement rates; Issues related to reimbursement for AI; and Issues related to breast & lung cancer screening.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Issues related to availability of medical isotopes.
Artificial Intelligence for Medical Devices, including issues related to Medicare reimbursement.
Issues related to Artificial Intelligence including Medicare reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
H.R. 2369 / S. 2496 - VA Loan Informed Disclosure Act of 202 (VALID) Act of 2023; H.R. 2377 / S.4449 - Saving Access to Laboratory Services Act; and Artificial Intelligence for Medical Devices, including issues related to Medicare reimbursement.
S. 1544, H.R. 1199, Facilitating Innovative Nuclear Diagnostics Act of 2023; H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Issues related to lung cancer screening programs; Issues related to Centers for Medicare & Medicaid Services conversion factor for physician fee schedule; Issues related to Medicare reimbursement rates; Issues related to clinical lab tests; Issues related to Artificial Intelligence for Medical Devices, including issues related to Medicare reimbursement; and Issues related to patient access to breakthrough products.
Issues related to Artificial Intelligence including Medicare reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to workforce development; and Issues related to Medicare payment for artificial intelligence.
Health care issues in general; and Issues related to cancer screening for veteran affairs.
Issues related to workforce development of allied healthcare professionals.
Issue related to site neutral payment policy; Issues related to Centers for Medicare & Medicaid Services conversion factor for physician reimbursement rates; Issues related to Medicare reimbursement rates; Issues related to clinical lab tests; and Issues related to Artificial Intelligence for Medical Devices, including issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to FDA guidance of Remanufacturing Medical Devices; Issues related to Right to Repair; Issued related to Artificial Intelligence; H.R.2369 - Verifying Accurate, Leading-edge IVCT Development (VALID) Act; Physician Fee Schedule/Reimbursement Issues; and Issues related to price transparency.
H.R. 1199 / S. 1544 - Facilitating Innovative Nuclear Diagnostics Act (FIND Act); Physician Fee Schedule / Reimbursement issues; Artificial Intelligence for Medical Devices, including issues related to Medicare reimbursement; H.R.2369 - Verifying Accurate, Leading-edge IVCT Development (VALID) Act; and Issues related to Transitional Coverage for Emerging Technologies;
Issues related to workforce development of allied healthcare professionals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Site neutral payment policy.
H.R. 1199: Facilitating Innovative Nuclear Diagnostics Act (FIND Act); HR 4006: the Fair Repair Act; HR 6566: the Freedom to Repair Act regarding right to repair and exempting medical devices; H.R. 1835/S. 1000 Saving Access to Laboratory Service Act of 2023 (SALSA Act); Physician Fee Schedule/Reimbursement Issues; Artificial Intelligence for Medical Devices; H.R. 3967 Honoring Our PACT Act, 2022.
Health care workforce shortages.
Remanufacturing Medical Devices (Clarifying Remanufacturing to Protect Patient Safety Act) Right to Repair; Artificial Intelligence for imaging devices; S.3648/H.R. 748 CARES Act; H.R. 925 Heroes Act; H.R. 2369 VALID Act of 2023; H.R. 3967 Honoring Our PACT Act, 2022; Physician Fee Schedule/Reimbursement Issues.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
FY 2024 Appropriations Bill: Labor Health and Human Services, Education and Related Agencies and Agriculture - diagnostic imaging equipment.
Health care workforce shortages.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE